ABO blood group is a predictor of survival in patients with laryngeal cancer

by Ting Jin, Pei-Jing Li, Xiao-Zhong Chen, Wei-Han Hu
Published 2016-10-01

Anti-PD1 checkpoint inhibitor with or without chemotherapy for patients with recurrent and metastatic nasopharyngeal carcinoma

by Ting Jin, Qun Zhang, Qi-Feng Jin, Yong-Hong Hua, Xiao-Zhong Chen
Published 2021-02-01

Metabolites Produced by the Endophytic Fungus Aspergillus fumigatus from the Stem of Erythrophloeum fordii Oliv.

by Yu-Sheng Shi, Yan Zhang, Xiao-Zhong Chen, Ning Zhang, Yun-Bao Liu
Published 2015-06-01

Endostar Combined with Gemcitabine and Cisplatin Chemotherapy for Patients with Metastatic Nasopharyngeal Carcinoma: an Update

by Ting Jin, Feng Jiang, Qi-Feng Jin, Yong-Feng Piao, Xiao-Zhong Chen
Published 2018-04-01

Oral Mucosa Dose Parameters Predicting Grade ≥3 Acute Toxicity in Locally Advanced Nasopharyngeal Carcinoma Patients Treated With Concurrent Intensity-Modulated Radiation Therapy a...

by Kaixin Li, Ling Yang, Qiang-ying Hu, Xiao-zhong Chen, Ming Chen, Yuanyuan Chen
Published 2017-10-01

Radiation dose escalation for locally advanced nasopharyngeal carcinoma patients with local and/or regional residual lesions after standard chemoradiotherapy: a non-randomized, obs...

by Ting Jin, Nan-Fang Liu, Qi-Feng Jin, Yong-Hong Hua, Xiao-Zhong Chen
Published 2022-11-01

Concurrent Chemoradiotherapy With or Without Induction Chemotherapy for Patients with Stage II Nasopharyngeal Carcinoma: An Update

by Ting Jin, Qun Zhang, Dong-Hua Luo, Feng Jiang, Qi-Feng Jin, Yuan-Yuan Chen, Xiao-Zhong Chen, Wei-Min Mao
Published 2020-01-01

Cisplatin and Fluorouracil Induction Chemotherapy With or Without Docetaxel in Locoregionally Advanced Nasopharyngeal Carcinoma

by Ting Jin, Wei-feng Qin, Feng Jiang, Qi-feng Jin, Qi-chun Wei, Yong-shi Jia, Xiao-nan Sun, Wen-feng Li, Xiao-zhong Chen
Published 2019-04-01

Predictive Model and Precaution for Oral Mucositis During Chemo-Radiotherapy in Nasopharyngeal Carcinoma Patients

by Pei-Jing Li, Kai-Xin Li, Ting Jin, Hua-Ming Lin, Jia-Ben Fang, Shuang-Yan Yang, Wei Shen, Jia Chen, Jiang Zhang, Xiao-Zhong Chen, Ming Chen, Yuan-Yuan Chen
Published 2020-11-01

TIPE3 hypermethylation correlates with worse prognosis and promotes tumor progression in nasopharyngeal carcinoma

by Xian-Yue Ren, Xin Wen, Ying-Qing Li, Jian Zhang, Qing-Mei He, Xiao-Jing Yang, Xin-Ran Tang, Ya-Qin Wang, Pan-Pan Zhang, Xiao-Zhong Chen, Bin Cheng, Jun Ma, Na Liu
Published 2018-09-01

Camrelizumab plus famitinib in patients with recurrent or metastatic nasopharyngeal carcinoma treated with PD-1 blockade: data from a multicohort phase 2 studyResearch in context

by Xi Ding, Yi-Jun Hua, Xiong Zou, Xiao-Zhong Chen, Xi-Mei Zhang, Bei Xu, Yan-Feng Ouyang, Zi-Wei Tu, Hui-Feng Li, Chong-Yang Duan, Wei-Jing Zhang, Rui You, You-Ping Liu, Yong-Long Liu, Qi Yang, Pei-Yu Huang, Shu-Ni Wang, Jia Fan, Ming-Yuan Chen
Published 2023-07-01

The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma

by Ling‐Long Tang, Yu‐Pei Chen, Chuan‐Ben Chen, Ming‐Yuan Chen, Nian‐Yong Chen, Xiao‐Zhong Chen, Xiao‐Jing Du, Wen‐Feng Fang, Mei Feng, Jin Gao, Fei Han, Xia He, Chao‐Su Hu, De‐sheng Hu, Guang‐Yuan Hu, Hao Jiang, Wei Jiang, Feng Jin, Jin‐Yi Lang, Jin‐Gao Li, Shao‐Jun Lin, Xu Liu, Qiu‐Fang Liu, Lin Ma, Hai‐Qiang Mai, Ji‐Yong Qin, Liang‐Fang Shen, Ying Sun, Pei‐Guo Wang, Ren‐Sheng Wang, Ruo‐Zheng Wang, Xiao‐Shen Wang, Ying Wang, Hui Wu, Yun‐Fei Xia, Shao‐Wen Xiao, Kun‐Yu Yang, Jun‐Lin Yi, Xiao‐Dong Zhu, Jun Ma
Published 2021-11-01